Ma Yuting, Researcher of Suzhou Institute of Systemic Medicine, Academy of Systemic Medicine, Chinese Academy of Medical Sciences, has been hailed for her dedication to work. She has been elected a delegate to the upcoming 20th National Congress of the Communist Party of China. Let’s take a close look.
At the Suzhou Institute of Systemic Medicine of the Chinese Academy of Medical Sciences in Suzhou Industrial Park, Ma Yuting was seen busy preparing for an animal experiment.
Xia Lin, an assistant researcher at the Suzhou Institute of Systemic Medicine of the Chinese Academy of Medical Sciences, said that Ma Yuting would give careful guidance to each student and design different experiments according to their different personalities and majors.
Ma Yuting is a researcher, director assistant and director of the immunization platform of Suzhou Institute of Systemic Medicine, Academy of Systemic Medicine, Chinese Academy of Medical Sciences.
She believed that scientific research should be done with a realistic attitude, so that we can really settle down, sharpen our sword in ten years, and make some meaningful and valuable achievements.
Ma Yuting studied in the School of Life Sciences of Huazhong University of Science and Technology as an undergraduate. In 2005, she was enrolled in an interdisciplinary examination in the Department of Immunology of Tongji Medical College before attending the 11th University of Paris, France to study for a doctor’s degree.
In 2015, she declined the invitations from many foreign scientific research institutions and joined the Suzhou Institute of Systemic Medicine to systematically study the regulation of cell stress on tumor immune response from the perspective of “stress and immune regulation” by taking radiotherapy and chemotherapy as the model.
Her research has provided a new idea of tumor treatment: appropriate drugs and doses can activate anti-tumor immune response, and eventually eliminate tumors through their own immune response.
Ma Yuting hoped to find some good targets in the course of the experiment to improve the vaccine and make it therapeutic.
Her research results were published in high-level academic journals such as Science and Natural Medicine. In addition, she has also made important breakthroughs in the regulation of tumor immunity by mental stress.
After repeated experiments, Ma Yuting’s team found glucocorticoid, the “accomplice” of stress inhibiting tumor treatment effect. It blocks glucocorticoid receptor with small molecule drugs, which can significantly improve the effect of chemotherapy, tumor vaccine and immunotherapy for various solid tumors. Her team also found biomarkers closely related to stress and prognosis of cancer patients.
This study has filled a cognitive gap in the world, and brought important enlightenment for clinical cancer treatment to pay attention to patients’ mental disorders and regulation by using glucocorticoids cautiously.
According to Ma Yuting, the world feels short of drugs to treat cancer pain. Pain killers are often addictive, so it is particularly necessary to develop new types of cancer pain treatment drugs, which can not only inhibit cancer pain, but also enhance tumor immunity in the direction she is exploring.
So far, Ma Yuting has published more than 50 research articles in the field of tumor immunity in international high-level journals such as Science with more than 6900 SCI citations.
China now strongly supports the innovation of the source of scientific research and encourages the discovery of original targets, mechanisms and drug molecules, which also gives Ma Yuting more confidence in taking the road of scientific research self-reliance in the future.
Ma Yuting said that as a front-line scientific and technological worker, it is a great honor to be elected as the delegate to the 20th National Congress of the Communist Party of China. During her attendance at the 20th National Congress of the Communist Party of China, she will actively learn from the new deployment of the Party and the government, especially the deployment for the development direction of science and technology frontiers, and repay the trust of the country and the people with scientific research achievements through her own efforts.
